N-tert-butyl-3-[[4-(3,3-dimethylbutyl)-2-pyridinyl]oxy]cyclobutan-1-amine;1-tert-butyl-4-[[1-(4,4-dimethylpentyl)azetidin-3-yl]methyl]piperazine;N-tert-butyl-3-[3-(2,2-dimethylpropoxy)phenoxy]cyclobutan-1-amine;N-tert-butyl-3-[[4-(2,2-dimethylpropoxy)-2-pyridinyl]oxy]cyclobutan-1-amine;2-tert-butyl-5-[[1-[2-[(2-methylpropan-2-yl)oxy]ethyl]azetidin-3-yl]methoxy]pyrazine;2-tert-butyl-5-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]pyrazine;4-tert-butyl-1-[1-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperidin-4-yl]piperidine
C131H235N17O9 — CID 167543519
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-tert-butyl-3-[[4-(3,3-dimethylbutyl)-2-pyridinyl]oxy]cyclobutan-1-amine;1-tert-butyl-4-[[1-(4,4-dimethylpentyl)azetidin-3-yl]methyl]piperazine;N-tert-butyl-3-[3-(2,2-dimethylpropoxy)phenoxy]cyclobutan-1-amine;N-tert-butyl-3-[[4-(2,2-dimethylpropoxy)-2-pyridinyl]oxy]cyclobutan-1-amine;2-tert-butyl-5-[[1-[2-[(2-methylpropan-2-yl)oxy]ethyl]azetidin-3-yl]methoxy]pyrazine;2-tert-butyl-5-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]pyrazine;4-tert-butyl-1-[1-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperidin-4-yl]piperidine
N-tert-butyl-3-[[4-(3,3-dimethylbutyl)-2-pyridinyl]oxy]cyclobutan-1-amine;1-tert-butyl-4-[[1-(4,4-dimethylpentyl)azetidin-3-yl]methyl]piperazine;N-tert-butyl-3-[3-(2,2-dimethylpropoxy)phenoxy]cyclobutan-1-amine;N-tert-butyl-3-[[4-(2,2-dimethylpropoxy)-2-pyridinyl]oxy]cyclobutan-1-amine;2-tert-butyl-5-[[1-[2-[(2-methylpropan-2-yl)oxy]ethyl]azetidin-3-yl]methoxy]pyrazine;2-tert-butyl-5-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]pyrazine;4-tert-butyl-1-[1-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperidin-4-yl]piperidine (PubChem CID 167543519) has the molecular formula C131H235N17O9 and a molecular weight of 2192.43 g/mol. Its IUPAC name is N-tert-butyl-3-[[4-(3,3-dimethylbutyl)-2-pyridinyl]oxy]cyclobutan-1-amine;1-tert-butyl-4-[[1-(4,4-dimethylpentyl)azetidin-3-yl]methyl]piperazine;N-tert-butyl-3-[3-(2,2-dimethylpropoxy)phenoxy]cyclobutan-1-amine;N-tert-butyl-3-[[4-(2,2-dimethylpropoxy)-2-pyridinyl]oxy]cyclobutan-1-amine;2-tert-butyl-5-[[1-[2-[(2-methylpropan-2-yl)oxy]ethyl]azetidin-3-yl]methoxy]pyrazine;2-tert-butyl-5-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]pyrazine;4-tert-butyl-1-[1-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperidin-4-yl]piperidine.
Molecular Properties
| Compound Name | N-tert-butyl-3-[[4-(3,3-dimethylbutyl)-2-pyridinyl]oxy]cyclobutan-1-amine;1-tert-butyl-4-[[1-(4,4-dimethylpentyl)azetidin-3-yl]methyl]piperazine;N-tert-butyl-3-[3-(2,2-dimethylpropoxy)phenoxy]cyclobutan-1-amine;N-tert-butyl-3-[[4-(2,2-dimethylpropoxy)-2-pyridinyl]oxy]cyclobutan-1-amine;2-tert-butyl-5-[[1-[2-[(2-methylpropan-2-yl)oxy]ethyl]azetidin-3-yl]methoxy]pyrazine;2-tert-butyl-5-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]pyrazine;4-tert-butyl-1-[1-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperidin-4-yl]piperidine |
|---|---|
| PubChem CID | 167543519 |
| Molecular Formula | C131H235N17O9 |
| Molecular Weight | 2192.43 g/mol |
| Exact Mass | 2190.85 |
| IUPAC Name | N-tert-butyl-3-[[4-(3,3-dimethylbutyl)-2-pyridinyl]oxy]cyclobutan-1-amine;1-tert-butyl-4-[[1-(4,4-dimethylpentyl)azetidin-3-yl]methyl]piperazine;N-tert-butyl-3-[3-(2,2-dimethylpropoxy)phenoxy]cyclobutan-1-amine;N-tert-butyl-3-[[4-(2,2-dimethylpropoxy)-2-pyridinyl]oxy]cyclobutan-1-amine;2-tert-butyl-5-[[1-[2-[(2-methylpropan-2-yl)oxy]ethyl]azetidin-3-yl]methoxy]pyrazine;2-tert-butyl-5-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]pyrazine;4-tert-butyl-1-[1-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperidin-4-yl]piperidine |
| SMILES | CC(C)(C)CCCN1CC(CN2CCN(C(C)(C)C)CC2)C1.CC(C)(C)CCc1ccnc(OC2CC(NC(C)(C)C)C2)c1.CC(C)(C)COc1cccc(OC2CC(NC(C)(C)C)C2)c1.CC(C)(C)COc1ccnc(OC2CC(NC(C)(C)C)C2)c1.CC(C)(C)OCCN1CC(COc2cnc(C(C)(C)C)cn2)C1.CC(C)(C)OCCN1CCC(N2CCC(C(C)(C)C)CC2)CC1.CC(C)(C)OCCN1CCN(c2cnc(C(C)(C)C)cn2)CC1 |
| InChI | InChI=1S/C20H40N2O.C19H39N3.C19H32N2O.C19H31NO2.C18H32N4O.C18H31N3O2.C18H30N2O2/c1-19(2,3)17-7-13-22(14-8-17)18-9-11-21(12-10-18)15-16-23-20(4,5)6;1-18(2,3)8-7-9-21-15-17(16-21)14-20-10-12-22(13-11-20)19(4,5)6;1-18(2,3)9-7-14-8-10-20-17(11-14)22-16-12-15(13-16)21-19(4,5)6;1-18(2,3)13-21-15-8-7-9-16(12-15)22-17-10-14(11-17)20-19(4,5)6;1-17(2,3)15-13-20-16(14-19-15)22-9-7-21(8-10-22)11-12-23-18(4,5)6;1-17(2,3)15-9-20-16(10-19-15)22-13-14-11-21(12-14)7-8-23-18(4,5)6;1-17(2,3)12-21-14-7-8-19-16(11-14)22-15-9-13(10-15)20-18(4,5)6/h17-18H,7-16H2,1-6H3;17H,7-16H2,1-6H3;8,10-11,15-16,21H,7,9,12-13H2,1-6H3;7-9,12,14,17,20H,10-11,13H2,1-6H3;13-14H,7-12H2,1-6H3;9-10,14H,7-8,11-13H2,1-6H3;7-8,11,13,15,20H,9-10,12H2,1-6H3 |
| InChIKey | BMPZOCMNKXSNDD-UHFFFAOYSA-N |
| XLogP | 25.37 |
| TPSA | 222.42 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 26 |
| Rotatable Bonds | 34 |
| Heavy Atoms | 157 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2192.43 |
| LogP ≤ 5 | 25.37 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 26 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 167543519 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.